Advancing Pediatric Medication Safety Using Real-world Data: Current Problems and Potential Solutions

Overview

Journal J Hosp Med

Publisher Wiley

Specialties General Medicine
Health Services

Date 2023 Mar 1

PMID 36855275

Authors

James W Antoon

James A Feinstein

Jennifer L Goldman

Kathryn E Kyler

Samir S Shah

Affiliations

Soon will be listed here.

Citing Articles

Major Drug-Drug Interaction Exposure Among Medicaid-Insured Children in the Outpatient Setting.

Kyler K, Hall M, Antoon J, Goldman J, Shah S, Tang Girdwood S Pediatrics. 2024; 153(2).

PMID: 38174350 PMC: 10842134. DOI: 10.1542/peds.2023-063506.

References

Antoon J, Hall M, Herndon A, Carroll A, Ngo M, Freundlich K . Prevalence of Clinically Significant Drug-Drug Interactions Across US Children's Hospitals. Pediatrics. 2020; 146(5). PMC: 7786820. DOI: 10.1542/peds.2020-0858. View

Hoon D, Taylor M, Kapadia P, Gerhard T, Strom B, Horton D . Trends in Off-Label Drug Use in Ambulatory Settings: 2006-2015. Pediatrics. 2019; 144(4). PMC: 7286122. DOI: 10.1542/peds.2019-0896. View

Lasser K, Allen P, Woolhandler S, Himmelstein D, Wolfe S, Bor D . Timing of new black box warnings and withdrawals for prescription medications. JAMA. 2002; 287(17):2215-20. DOI: 10.1001/jama.287.17.2215. View

Beskow L, Lindsell C, Rice T . Consent for Acute Care Research and the Regulatory "Gray Zone". Am J Bioeth. 2020; 20(5):26-28. PMC: 7371242. DOI: 10.1080/15265161.2020.1745950. View

Whitmore C, Hawley R, Min J, Mitchel Jr E, Daugherty J, Griffin M . Building a Data Linkage Foundation for Mother-Child Pharmacoepidemiology Research. Pharmaceut Med. 2020; 35(1):39-47. DOI: 10.1007/s40290-020-00371-8. View

Desai R, Matheny M, Johnson K, Marsolo K, Curtis L, Nelson J . Broadening the reach of the FDA Sentinel system: A roadmap for integrating electronic health record data in a causal analysis framework. NPJ Digit Med. 2021; 4(1):170. PMC: 8688411. DOI: 10.1038/s41746-021-00542-0. View

Cocoros N, Fuller C, Adimadhyam S, Ball R, Brown J, Dal Pan G . A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel System. Pharmacoepidemiol Drug Saf. 2021; 30(7):827-837. PMC: 8250843. DOI: 10.1002/pds.5240. View

Shah S, Hall M, Goodman D, Feuer P, Sharma V, Fargason Jr C . Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007; 161(3):282-90. DOI: 10.1001/archpedi.161.3.282. View

Kostis J, Dobrzynski J . Limitations of Randomized Clinical Trials. Am J Cardiol. 2020; 129:109-115. DOI: 10.1016/j.amjcard.2020.05.011. View

10.

Goldberg N, Schneeweiss S, Kowal M, Gagne J . Availability of comparative efficacy data at the time of drug approval in the United States. JAMA. 2011; 305(17):1786-9. DOI: 10.1001/jama.2011.539. View

11.

Franklin J, Liaw K, Iyasu S, Critchlow C, Dreyer N . Real-world evidence to support regulatory decision making: New or expanded medical product indications. Pharmacoepidemiol Drug Saf. 2021; 30(6):685-693. DOI: 10.1002/pds.5222. View

12.

Coon E, Bonafide C, Cohen E, Heath A, McDaniel C, Schroeder A . HEROIC Trials to Answer Pragmatic Questions for Hospitalized Children. Hosp Pediatr. 2022; 12(9):e312-e318. DOI: 10.1542/hpeds.2022-006617. View

13.

Sachs A, Avant D, Lee C, Rodriguez W, Murphy M . Pediatric information in drug product labeling. JAMA. 2012; 307(18):1914-5. DOI: 10.1001/jama.2012.3435. View

14.

Huang Y, Moon J, Segal J . A comparison of active adverse event surveillance systems worldwide. Drug Saf. 2014; 37(8):581-96. PMC: 4134479. DOI: 10.1007/s40264-014-0194-3. View

15.

Bar-On Y, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Kalkstein N . Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel. N Engl J Med. 2021; 385(15):1393-1400. PMC: 8461568. DOI: 10.1056/NEJMoa2114255. View

16.

Pacurariu A, Plueschke K, McGettigan P, Morales D, Slattery J, Vogl D . Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation. BMJ Open. 2018; 8(9):e023090. PMC: 6129090. DOI: 10.1136/bmjopen-2018-023090. View

17.

Yih W, Lieu T, Kulldorff M, Martin D, McMahill-Walraven C, Platt R . Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med. 2014; 370(6):503-12. DOI: 10.1056/NEJMoa1303164. View

18.

Hause A, Baggs J, Marquez P, Myers T, Su J, Hugueley B . Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022. MMWR Morb Mortal Wkly Rep. 2022; 71(33):1047-1051. PMC: 9400528. DOI: 10.15585/mmwr.mm7133a3. View